AI Insight
University of Florida neuroscientists have identified an association between glucosamine supplementation, commonly used for joint pain relief, and an increased risk of progression from mild cognitive impairment to Alzheimer's disease. The findings are based on a large-scale retrospective analysis of patient medical records, supplemented by advanced brain imaging studies of human tissue specimens and Alzheimer's disease mouse models. The research suggests that this widely available over-the-counter supplement may have unexpected neurological effects.
Why it matters
Glucosamine is one of the most commonly used dietary supplements globally, with millions of people taking it regularly for joint health. This research raises important safety concerns about a product widely considered benign and could influence clinical recommendations for individuals at risk of cognitive decline.
Understand the Science
New research has found an association between taking glucosamine, a popular over-the-counter supplement used for joint pain, and a higher likelihood of progressing from mild cognitive impairment to Alzheimer’s disease. The finding by University of Florida neuroscientists is based on a large retrospective analysis of patients’ records as well as supporting data from advanced imaging technology used to scan human brain specimens and Alzheimer’s disease mouse models.
Source: A popular joint pain supplement may accelerate dementia